| Features | |
| Also known as | TH9507 |
| Blood pressure | Typically no significant impact on blood pressure |
| Chemical name | (trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl |
| Dosage (medical) | 2 mg injected subcutaneously once daily |
| Dosage (sports) | Not applicable as it is not typically used for sports enhancement |
| Effects | Increases natural production of growth hormone |
| Formula | C221H366N72O67S |
| Half-life | Approximately 38 minutes |
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring of IGF-1 levels may be used to assess efficacy |
| Main action | Growth hormone-releasing hormone (GHRH) analog |
| Side effects | Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Strength | 2 mg |
| Substance class | Peptide hormone |
| Trade name | Egrifta |
| Use in sports | Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy |
| Water Retention | Minimal |
| Manufacturer | Pharmaceutical |
-
48.00€
| Brand: | Moldavian Pharma |
|---|---|
| Product Code: | EU18926 |
| Availability: | In stock |
Delivery information
Please note! If you have ordered a product worth €300.
We deliver the goods at our own expense! If the check amount is between €150 and €300, the delivery charge is €20.
For check amounts up to €200, shipping costs are €35.